Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
Why loss of confidence in previously published findings does not necessarily lead to self-correction of the scientific record
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
Detectives are on the hunt for fake research papers: Nature analysis investigates the paper mill problem
Nature analyses the ongoing battle publishers are facing against paper mills and what editors are doing to identify these fake articles.
European countries can’t agree on what counts as research misconduct, creating potential pitfalls for researchers.
Combatting research integrity breaches: insights from Suzanne Farley, Director of the Springer Nature Research Integrity Group
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
Acceleration of research and implications for research transparency: our summary of the third Biomedical Transparency Summit series webinar
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
Research integrity across the Atlantic: our summary of the first Biomedical Transparency Summit series webinar
Find out more about what was covered during the first 2021 webinar from the Center for Biomedical Research Transparency.
Find out how principles of research integrity can be put into practice to combat fraud and misconduct.
Two articles explore how the use of metrics has enabled the evolution of new types of scientific fraud, including citation manipulation.